WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):
-Earnings: -$138.65 million in Q1 vs. -$119.63 million in the same period last year. -EPS: -$0.78 in Q1 vs. -$0.69 in the same period last year. -Analysts projected -$0.71 per share -Revenue: $50.57 million in Q1 vs. $28.22 million in the same period last year.
Copyright RTT News/dpa-AFX